Related Experiment Videos
Adverse reactions to intravenous cholangiography with Biligram
European Journal of Radiology
|August 1, 1984
Abstract:
During the seven year period 1976-82 3937 intravenous cholangiographies were performed with thirty-three adverse reactions to the contrast medium Biligram considered to require treatment. One patient died. The frequency of adverse reactions to intravenous cholangiography with Biligram is no reason for abandoning the method.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Prognostic factors in patients with symptomatic spinal metastases and normal neurological function.
Clinical oncology (Royal College of Radiologists (Great Britain))·2015
MRI and neurological findings in patients with spinal metastases.
Acta radiologica (Stockholm, Sweden : 1987)·2012
Dural ectasia in Marfan syndrome: a case control study.
AJNR. American journal of neuroradiology·2009
A piglet model for detection of hypoxic-ischemic brain injury with magnetic resonance imaging.
Acta radiologica (Stockholm, Sweden : 1987)·2008
Altered Blood-Brain Barrier Water Exchange in Remission-Phase Neuromyelitis Optica Spectrum Disorder: A WEPCAST MRI Study.
European journal of radiology·2026
Predicting TERT mutation in glioma patients using MRI-derived radiomics; A systematic review and meta-analysis.
European journal of radiology·2026
Prognostic value of pericoronary adipose tissue attenuation in cardiovascular outcomes: a systematic review and meta-analysis.
European journal of radiology·2026
Transcatheter Aortic Valve Replacement or Medical Treatment for Paradoxical Low-Flow, Low-Gradient Aortic Valve Stenosis: REBOOT-PARADOX.
Journal of the American College of Cardiology·2026
A multicenter prospective observational cohort study to improve diagnostic yield and clinical management of persons with a Bleeding Disorder of Unknown Cause (BDUC-iN study protocol).
Research and practice in thrombosis and haemostasis·2026
Avatrombopag in thrombopoietin receptor agonist-naïve patients with immune thrombocytopenia: real-world treatment patterns and clinical outcomes from the REAL-AVA 3.0 study.
Research and practice in thrombosis and haemostasis·2026
Retraction: Targeted plasmalogen supplementation: effects on blood plasmalogens, oxidative stress biomarkers, cognition, and mobility in cognitively impaired persons.
Frontiers in cell and developmental biology·2026